Photo taken from Narayanahealth.org
Aug 9, 2024, 16:01
Re-sensitizing cancer to previously effective treatments – Ovarian Cancer Research Alliance
Ovarian Cancer Research Alliance shared on X:
“The potential for re-sensitizing cancer to previously effective treatments opens up new options in the battle against Platinum-Resistant/Refractory Ovarian Cancer (PRROC).”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 12:51
Aug 6, 2025, 12:09
Aug 6, 2025, 11:45
Aug 6, 2025, 09:33
Aug 6, 2025, 09:22